Vanberra Signal

Apriori Bio

Curated by Signal

AI-based infection control and vaccine prediction tool for healthcare

Overview

AI-based infection control and vaccine prediction tool for healthcare. The company has developed a biological intecation-based product that uses AI technology for the detection of viral components. The technology has the ability to identify virus variants for vaccine production and infection control.

Key facts

Founded
2020

Business model

Contact

Open roles

1 role
  • Director, Program Management

    Somerville, MA · On-site · Volunteer

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider cloud based communication solutions for health plans, employers and providers

    Health TechnologyIndianapolis, United States
  • AI-powered medical image management platform

    Health TechnologySunnyvale, United States
  • Develops apps for education and interpreting results of medical reports

    Health TechnologyAnn Arbor, United States

About Apriori Bio

What does Apriori Bio do?

AI-based infection control and vaccine prediction tool for healthcare.

Where is Apriori Bio headquartered?

Apriori Bio is headquartered in Belmont, United States.

When was Apriori Bio founded?

Apriori Bio was founded in 2020.

Which sector is Apriori Bio in?

Apriori Bio operates in Health Technology.

Who are Apriori Bio's competitors?

Companies similar to Apriori Bio include Healthx, Nexus-MD, and Free Radical.

Is Apriori Bio hiring?

Yes. Apriori Bio has 1 open role listed on Vanberra Signal.